logo
ADHD is not really on the rise, study suggests

ADHD is not really on the rise, study suggests

Telegraph2 days ago

ADHD is not rising despite public perception that cases are increasing, a study suggests.
Researchers at King's College London found little evidence to suggest that the prevalence of attention deficit hyperactivity disorder was getting worse, and said many studies suggesting an increase were of too low quality to be trusted.
Dr Alex Martin, lecturer in psychology at King's, said: 'The media has been concerned about a 'surge' in ADHD diagnoses for several years.
'While assessments and help-seeking may be increasing, our study has shown significant gaps in the tracking of ADHD prevalence, resulting in a frustratingly unclear picture.
'The best data we have suggests that there has been no meaningful increase in ADHD prevalence, but most of the research is too biased to draw conclusions from.'
Anecdotal reports suggest that the UK has had an unprecedented rise in the number of children and adults seeking support for ADHD, with significant backlogs of people currently awaiting assessment.
The demand for ADHD diagnoses has exacerbated pressures on the NHS, with a survey by the Pensions Committee in 2023 finding that about one in four people faced delays of two years while one in 10 waited 10 years for an assessment.
There were fears that the Covid pandemic and social media may have exacerbated the problem, with many more youngsters experiencing mental health issues during lockdowns.
But while calls for assessments are growing, there is little evidence to suggest it was leading to a rise in the overall prevalence of the condition, the study found.
The team discovered that studies suggesting ADHD rates were rising were of low quality, using self-reporting surveys, or reported symptoms from parents and teachers, rather than actual clinical diagnoses.
increased awareness, rather than more cases.
Between January and May last year, there were 25,080 media articles published on ADHD compared with 5,775 articles in the same period in 2014.
The growth of the ' neurodiversity movement ' may also have played a role in raising the profile of the condition and encouraging more people to seek help.
Edmund Sonuga-Barke, professor of developmental psychology at King's, said: 'The neurodiversity movement, with its concentration on personal lived experience and self-compassion as the ultimate reference point for decision-making, is likely driving cultural change.
'In this regard, it's potentially increasing rates of self-referral among adolescents and adults.'
In the UK, it's estimated that ADHD affects about 3-5 per cent of children and adults.
The US has far higher rates, with nearly 12 per cent of youngsters diagnosed with the condition. This has led to a crackdown by the Trump administration on over-prescribing of ADHD drugs to youngsters.
Prof Sonuga-Barke said US and UK rates were likely to be similar and he agreed there should be an investigation.
'Language of distress'
'I think the prevalence of ADHD is very similar in the US and the UK,' he said. 'I think there's grounds for an investigation to the impact of the prescriptive prescribing rates in the States.'
A recent BBC investigation suggested that at least 196,000 adults were on NHS waiting lists for ADHD assessments.
But researchers said that greater awareness of the condition might also mean that young people are now using the term ADHD as 'language of distress', to signal they are struggling, even though they do not have the condition.
Prof Phillip Shaw, director of the King's Maudsley Partnership for Children and Young People at King's, said: 'There's both an increased recognition and less stigma around ADHD, which means that people are increasingly coming forward for assessment.
'My hunch is that there's such a huge awareness of ADHD that it's often used as a language of distress.
'It's sometimes used, I suspect, by young people who are expressing that they are struggling, particularly at school, and need help.'
This study was funded by NHS England and was conducted by the NIHR Health Protection Research Unit in Emergency Preparedness and Response.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Millions to receive NHS screening invitations and appointment reminders on their phones
Millions to receive NHS screening invitations and appointment reminders on their phones

Sky News

time24 minutes ago

  • Sky News

Millions to receive NHS screening invitations and appointment reminders on their phones

Appointment reminders, invitations to health screenings and test results will now be received by patients on their phones. The government says moving to a more digital-focused NHS will mean 50 million fewer letters need to be sent out by the health service, saving an estimated £200m over the next three years. Instead, under the new plans, millions of people will be notified about appointments and other important notices via the NHS app on their phone or digital device. The app is set to become the go-to method for the NHS to communicate with people, the Department of Health and Social Care said. The changes will be backed by more than £50m investment. It will see a predicted 270 million messages sent through the app this year, an increase of around 70 million on the last financial year, the government announced. Wes Streeting has said this is all about modernising, as the NHS "feels so 20th century". The health secretary said: "The fact that people still get letters through the front door, sometimes multiple letters about the same appointment... The NHS has been stuck in the mud when it comes to the everyday technology we use to organise our lives. And that's why what we're doing with the NHS app is really exciting." Mr Streeting said the app will make using the NHS more convenient, and give patients more control, while saving money. He said these funds can then be invested back into the health service, to bolster things such as frontline care. Using the NHS app should be 'as joyful as Netflix' The modernisation of the NHS will also lead to fewer missed appointments, and therefore save money that way too, it is hoped. In 2023/24, there were around eight million missed appointments in elective care and almost one in three people missed a screening appointment. Currently, around 20 million people have opted in to receive messages from the NHS app. 4:01 Pushed on how the government will ensure that nobody is left behind, Mr Streeting said: "If someone like me is booking my appointment through the app because that's what I prefer to do, [then] that's freeing up a phone line for someone who wants to get through and talk to a person." He added that greater use of the app will give people more choice in "how you want to organise your care". The cabinet minister also made a bold comparison, saying he wishes that the NHS app is as enjoyable as using streaming giant Netflix. He said: "The NHS app actually has more subscribers than Netflix. It would be a really wonderful thing if using the NHS app felt - if not as joyful - almost as joyful as using Netflix." Other features in the pipeline - though not yet available - include being able to add appointments to phone calendars and request help from local GPs on the app. Faster log in methods, such as using Face ID, are also planned.

Statins almost halve the risk of death in patients critically ill with sepsis
Statins almost halve the risk of death in patients critically ill with sepsis

Daily Mail​

time35 minutes ago

  • Daily Mail​

Statins almost halve the risk of death in patients critically ill with sepsis

Taking statins can improve the chances of surviving sepsis by 40 per cent, a trial has found. Sepsis can occur when the body's immune system overreacts to an infection and attacks its own organs. It is notoriously difficult to spot because the telltale symptoms, such as a fever and muscle pain, can be easily mistaken for signs of a common cold or other infection. Statins lower cholesterol to prevent heart attacks and strokes and are taken by around 5 million adults in the UK. But experts say they have other benefits, including reducing inflammation and fighting bacteria that can ultimately lead to sepsis. The study compared survival rates of sepsis patients given statins and those who were not during a hospital stay. It found the pills reduced the risk of death for those critically ill with the condition by 39 per cent. The study compared survival rates of sepsis patients given statins and those who were not during a hospital stay. It found the pills reduced the risk of death for those critically ill with the condition by 39 per cent (file image) In intensive care, 14.3 per cent of 6,000 sepsis patients given statins died within 28 days, compared with 23.4 per cent of 6,000 patients who were not. For those no longer in a critical condition, 11 per cent given statins died compared to 19 per cent who were not. Dr Caifeng Li, of Tianjin Medical University General Hospital in China and the study's author said: 'These results suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' Researchers believe the drugs may help with sepsis by helping to combat bacteria directly, reducing the toll infection takes on the body. Earlier this year another study found the pills could also slash dementia risk – even in patients who don't have high cholesterol. The sepsis study, published in the journal Frontiers in Immunology, was based on data from thousands of patients at an Israeli hospital over a decade. Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, said: 'This study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.' Sepsis is known as the 'silent killer'. For every hour of delay in treatment, a patient's chance of dying increases 8 per cent. If caught early, it can be treated with antibiotics and fluids. Symptoms include slurred speech or confusion, shivering or muscle pain, passing no urine in a day, severe breathlessness and mottled or discoloured skin. Blood test to spot Alzheimer's early A Blood test for Alzheimer's can accurately detect the disease early, a study suggests. The test was 95 per cent accurate in identifying people with memory problems. It also scored 82 per cent for specificity, which means it was highly accurate in ruling out people without dementia. The study, published in the journal Alzheimer's and Dementia, found proteins amyloid beta 42/40 and p-tau217 in blood plasma can be examined to diagnose the condition. The study was carried out on more than 500 people in an outpatient memory clinic. The blood test has already been approved by the Food and Drug Administration regulator in the US.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store